SCHEMBL13616490

SCHEMBL13616490

C/C=N/N1CCN(Cc2ccc(-c3ccc(Cl)cc3)s2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
PKM P14618 2/20 0.44
MAPK1 P28482 5/20 0.42
GAA P10253 3/20 0.42
KDM4E B2RXH2 3/20 0.42
TDP1 Q9NUW8 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 3/20 0.41
INPPL1 O15357 2/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13616567 0.89 MAPK1 (0.49) ALDH1A1MAPK1GAAKDM4ETDP1
SCHEMBL13616489 0.87 L3MBTL1 (0.47) ALDH1A1MAPK1GAAKDM4ETDP1
SCHEMBL4310428 0.79 INPPL1 (0.42) ALDH1A1KDM4ETDP1SMN1; SMN2INPPL1
SCHEMBL13940662 0.78 INPPL1 (0.44) ALDH1A1MAPK1KDM4ETDP1SMN1; SMN2
SCHEMBL32667411 0.76 ALDH1A1 (0.55) ALDH1A1TDP1INPPL1NPC1RAB9A
SCHEMBL13616492 0.75 ALDH1A1 (0.68) ALDH1A1PKMMAPK1GAAKDM4E
SCHEMBL13616494 0.73 NOTUM (0.49) ALDH1A1PKMMAPK1GAAKDM4E
SCHEMBL13616468 0.72 NOTUM (0.48) ALDH1A1PKMTDP1SMN1; SMN2MAPT
SCHEMBL28321103 0.69 KDM4E (0.56) ALDH1A1KDM4ETDP1SMN1; SMN2POLB
SCHEMBL13616496 0.68 NOTUM (0.46) SMN1; SMN2MAPTPOLBL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275594-A1 3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS JANSSEN PHARMACEUTICA NV (BE) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275594-A1 3-HYDRAZONE PIPERAZINYL RIFAMYCIN DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS RIF1, ABCC1, HDAC6 ALDH1A1 1070/4885PKM 835/4885MAPK1 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.